Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
CNY 5.25
(-2.42%)
CNY 5.25
(-2.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 12.42 Million | 57.13 Million | 108.28 Million | 224.53 Million | 231.29 Million | 225.88 Million |
| Net Income | -8.92 Million | -76.28 Million | -105.93 Million | -344.65 Million | -161.39 Million | 91.13 Million |
| Depreciation & Amortization | 75.41 Million | 76.4 Million | 74.76 Million | 108.78 Million | 108.5 Million | 107.42 Million |
| Deferred income taxes | 5.93 Million | -9.17 Million | -12.68 Million | -9.58 Million | -22.79 Million | -4.3 Million |
| Stock-based compensation | 26.28 Million | 1.92 Million | 4.26 Million | 12.75 Million | - | - |
| Change in working capital | 28.26 Million | 66.1 Million | 114.45 Million | 137.43 Million | 26.97 Million | -26.97 Million |
| Other non-cash items | 34.29 Million | -9.08 Million | 24.99 Million | 322.97 Million | 257.2 Million | 54.3 Million |
| Investing Cash Flow | -119.51 Million | 13.81 Million | 157.19 Million | -110.96 Million | -88 Million | -319.19 Million |
| Investments in PPE | -59.31 Million | -68.18 Million | -38.65 Million | -43.57 Million | -63.06 Million | -125.93 Million |
| Acquisitions | 12.39 Million | 1210.00 | 78.29 Million | 10.47 Thousand | -6.91 Million | 158.71 Thousand |
| Investment purchases | -13.25 Million | -45.45 Million | -92.36 Million | -809.46 Million | -461.91 Million | -537.29 Million |
| Sales/Maturities of investments | 61.36 Million | 126.37 Million | 216.98 Million | 740.91 Million | 435.17 Million | 305.17 Million |
| Other Investing Activities | -120.7 Million | 1.07 Million | -7.06 Million | 1.14 Million | 8.71 Million | 38.7 Million |
| Financing Cash Flow | -102.41 Million | 166.06 Million | 36.05 Million | -61.36 Million | -132.63 Million | 107.38 Million |
| Debt repayment | -59.03 Million | -203.21 Million | -1.04 Billion | -1.41 Billion | -1.01 Billion | -584.67 Million |
| Dividends payments | -11.8 Million | -17.46 Million | -29.08 Million | -40.61 Million | -40.61 Million | -93.89 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -31.56 Million | 386.74 Million | 1.11 Billion | 1.46 Billion | 985.73 Million | 785.95 Million |
| Accounts receivables | 51.38 Million | 142.17 Million | -54.29 Million | 166.99 Million | -370.11 Million | -162.5 Million |
| Accounts payables | -50.76 Million | -20.23 Million | 118.09 Million | -33.47 Million | 438.06 Million | 107.79 Million |
| Inventory | 27.64 Million | -46.65 Million | 63.33 Million | 13.49 Million | -18.17 Million | 32.02 Million |
| Other working capital | 82.58 Million | -9.17 Million | -12.68 Million | -9.58 Million | -22.79 Million | -59 Million |
| Cash at beginning of period | 846.28 Million | 555.04 Million | 254.37 Million | 203.29 Million | 193.23 Million | 173.24 Million |
| Cash at end of period | 836.43 Million | 794.82 Million | 555.04 Million | 254.37 Million | 203.29 Million | 193.23 Million |
| Capital Expenditure | -59.31 Million | -68.18 Million | -38.65 Million | -43.57 Million | -63.06 Million | -125.93 Million |
| Effect of forex changes on cash | 567.07 Thousand | 2.76 Million | -862.65 Thousand | -1.12 Million | -601.27 Thousand | 5.91 Million |
| Net cash flow / Change in cash | -9.84 Million | 239.78 Million | 300.66 Million | 51.08 Million | 10.05 Million | 19.99 Million |
| Free Cash Flow | -46.89 Million | -11.05 Million | 69.62 Million | 180.96 Million | 168.23 Million | 99.95 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -27.74 Million | 5.9 Million | -4.57 Million | -8.92 Million | 45.58 Million | -456.92 Thousand |
| Depreciation & Amortization | - | 14.77 Million | - | 75.41 Million | 19.4 Million | 19.4 Million |
| Deferred income taxes | - | - | - | 5.93 Million | -187.9 Million | - |
| Stock-based compensation | - | - | - | 26.28 Million | 26.28 Million | - |
| Change in working capital | - | - | - | 28.26 Million | 161.61 Million | -37.58 Million |
| Other non-cash items | 70.73 Million | 69.58 Million | 84.14 Million | 34.29 Million | -95.82 Million | 43.43 Million |
| Investing Cash Flow | 25.07 Million | -29.56 Million | 10.95 Million | -119.51 Million | -121.69 Million | -15.99 Million |
| Investments in PPE | -18.4 Million | -19.42 Million | -19.37 Million | -59.31 Million | -13.95 Million | -16.85 Million |
| Acquisitions | 3.4 Million | 400.00 | 30.95 Thousand | 12.39 Million | 12.23 Million | 155.17 Thousand |
| Investment purchases | -5.76 Million | - | - | -13.25 Million | -6.73 Million | -2.76 Million |
| Sales/Maturities of investments | - | 636.32 Thousand | 2.84 Million | 61.36 Million | 7.45 Million | 3.49 Million |
| Other Investing Activities | 43.48 Million | -10.78 Million | 27.45 Million | -120.7 Million | -120.68 Million | -22.62 Thousand |
| Financing Cash Flow | 135.74 Million | -50.35 Million | 28.27 Million | -102.41 Million | -22.89 Million | 30.86 Million |
| Debt repayment | -128.55 Million | -30.5 Million | -21 Million | -59.03 Million | -8.39 Million | -38.5 Million |
| Dividends payments | -2.79 Million | -7.62 Million | -2.46 Million | -11.8 Million | -22.95 Million | -3.64 Million |
| Common Stock Repurchased | - | - | - | - | -9.13 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 9.98 Million | -16.86 Million | 9.74 Million | -31.56 Million | 8.46 Million | 73 Million |
| Accounts receivables | - | - | - | 51.38 Million | 51.38 Million | 23.8 Million |
| Accounts payables | - | - | - | -50.76 Million | - | - |
| Inventory | - | - | - | 27.64 Million | 27.64 Million | -9.62 Million |
| Other working capital | - | - | - | 82.58 Million | 82.58 Million | -51.76 Million |
| Cash at beginning of period | 768.04 Million | 926.82 Million | 668.57 Million | 846.28 Million | 828.63 Million | 712.28 Million |
| Cash at end of period | 986.47 Million | 921.08 Million | 787.09 Million | 836.43 Million | 836.43 Million | 761.77 Million |
| Capital Expenditure | -18.4 Million | -19.42 Million | -19.37 Million | -59.31 Million | -13.95 Million | -16.85 Million |
| Effect of forex changes on cash | -831.9 Thousand | 155.72 Thousand | 63.21 Thousand | 567.07 Thousand | -464.49 Thousand | -199.58 Thousand |
| Net cash flow / Change in cash | 218.43 Million | -5.74 Million | 118.51 Million | -9.84 Million | 7.8 Million | 49.49 Million |
| Free Cash Flow | 24.58 Million | 41.29 Million | 60.19 Million | -46.89 Million | -44.79 Million | 7.94 Million |
6649
KINGSINFR
UAVS
7738
VMRI
002145